Structural biology has enabled key advances in biochemistry, drug discovery, and AI-driven three-dimensional structure modelling. Despite its centrality, no general and reliable computational tools exist to chemically validate structural models, especially when small-molecule ligands are involved. This challenge is exacerbated when experimental resolution is insufficient to define interaction chemistry, leaving critical interpretations ambiguous. We introduce In-Pocket, a quantum mechanical optimisation method biased by experimental data that resolves the chemical nature of protein-ligand binding interfaces. In-Pocket improves model quality, corrects chemically inconsistent structures, and identifies the energetically most favourable conformers within biomacromolecular complexes. Further, it generalises across a wide range of systems, including those containing transition metals. Benchmarking demonstrates that In-Pocket enhances the reliability of legacy and newly solved structures. With automated and simple-to-use routine chemical validation, In-Pocket stands to improve the integrity of structural databases and impact diverse domains: from molecular biology to rational drug design and application of generative AI.
No takes yet. Share an insight, caveat, or question.
Menezes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: